Related Experiment Video
Updated: Jul 20, 2025

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center.
Fahad I Alsohaibani1, Musthafa C Peedikayil1, Abdulaziz F Alfadley2
1Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Progressive familial intrahepatic cholestasis (PFIC) is rare, with PFIC type 3 being most common in Saudi Arabia. Liver transplantation is effective, with a 64.6% rate and excellent survival, highlighting the need for early diagnosis.
Area of Science:
- Hepatology
- Genetics
- Pediatric Gastroenterology
Background:
- Progressive familial intrahepatic cholestasis (PFIC) encompasses rare genetic disorders impacting bile secretion mechanisms.
- Understanding PFIC subtypes, clinical presentations, and treatment outcomes is crucial for patient management.
Purpose of the Study:
- To characterize the types, clinical features, treatment modalities, and outcomes of PFIC in Saudi Arabia.
- To evaluate the effectiveness of liver transplantation for PFIC patients in the region.
Main Methods:
- A retrospective study analyzed 79 PFIC patients diagnosed between 2002 and 2021 at King Faisal Specialist Hospital and Research Center, Riyadh.
- Data on PFIC types, genetic mutations, liver transplantation, and post-transplant outcomes were collected and statistically analyzed.
Main Results:
- PFIC type 3 was most prevalent (59.5%), followed by type 2 (34.2%), type 1 (5.1%), and type 4 (1.3%).
- Genetic mutations identified included ATP8B1, ABCB11, ABCB4, and TJP2 variants.
- A significant proportion (64.6%) of patients underwent liver transplantation, achieving excellent symptomatic control (92.2%) and a high five-year survival rate.
Conclusions:
- PFIC is rare in Saudi Arabia, but early recognition and referral for liver transplantation are vital.
- Liver transplantation demonstrates a high success rate and excellent survival for PFIC patients in this cohort.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

